Earnings360 Newsletter for 4/10/2025

Do NOT Buy SpaceX – Do This Instead (ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors.

Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.

Read Tilson's free analysis and find out what to do with your money

Top Earnings News

The total return for StoneX Group (NASDAQ:SNEX) investors has risen faster than earnings growth over the last five years

HEICO (NYSE:HEI) Reports Strong Q1 2025 Earnings Amid Volatile Market

Elon says the ‘S’ word

RPM International Analysts Slash Their Forecasts After Downbeat Earnings

Amazon Stock Bounces From Lows as Smart Money Steps In

General Motors: When Good News Isn’t Good Enough

The 7 Stocks Quietly Gaining Attention Right Now (ad)

Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.

A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful.

See the 7 stocks on the watchlist while it's still free

Thursday, April 10 Today's Earnings Announcements

Company	Current Price	Consensus EPS	Actual EPS	Beat/Miss	Consensus Revenue	Actual Revenue	YoY Revenue Growth	Report
CVAC CureVac	$4.66	($0.14)	($0.15)	($0.01)	$6.40 million	$15.44 million		→
KMX CarMax	$51.09	$0.66	Reports before open		$5.93 billion	$6.00 billion	6.7%	→
TSCDY Tesco	$21.58	$0.4488	Reports before open		$43.10 billion	$43.10 billion		→

FDA clears next-gen therapy with 10 to 40 times greater potency (ad)

Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden.

One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency, has just cleared an important FDA milestone.

Watch the microscopic footage and learn about the next catalyst

Wednesday, April 9 Yesterday's Earnings Announcements

Company	Current Price	Consensus EPS	Actual EPS	Beat/Miss	Consensus Revenue	Actual Revenue	YoY Revenue Growth	Report
DAL Delta Air Lines	$76.46	$0.84	$0.46	($0.38)	$13.85 billion	$12.98 billion	-5.6%	→
NEOG Neogen	$12.26	$0.12	$0.10	($0.02)	$225.27 million	$221 million	-3.4%	→
PSMT PriceSmart	$169.25	$1.51	$1.45	($0.06)	$1.34 billion	$1.36 billion	5.6%	→
STZ Constellation Brands	$138.14	$2.28	$2.63	$0.35	$2.14 billion	$2.13 billion	1.2%	→
SVNDY Seven and I	$13.47	$0.23	$0.12	($0.11)	$18.47 billion	$19.70 billion		→
TBBB BBB Foods	$58.06	$1.02	($0.01)	($1.03)	$16.87 billion	$784.03 million		→

Trump goes "all-in" on Grand Canyon energy breakthrough (ad)

A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.

While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.

One company controls the entire supply chain behind this discovery.

See the ticker behind this Grand Canyon energy breakthrough now

Earnings360 Newsletter for 4/10/2025

Thursday, April 10 Today's Earnings Announcements

Wednesday, April 9 Yesterday's Earnings Announcements

MarketBeat Earnings Tools

Get Earnings Reports, Analysts' Forecasts, and Conference Call Transcripts.